[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100297187":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":13,"centralContacts":18,"locations":24,"responsibleParty":42,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":7,"eligibilityCriteria":52,"healthyVolunteers":53,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":7,"overallStatus":27,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"The First Affiliated Hospital of Soochow University","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"BIOLOGICAL","Fecal microbiota","fecal microbiota transplantation",[14],{"name":15,"affiliation":16,"role":17},"depei wu","first affiliated of Soochow university","STUDY_CHAIR",[19],{"name":20,"role":21,"phone":22,"phoneExt":7,"email":23},"xiaofei qi","CONTACT","1-86-512-67780410","qixiaofei@suda.edu.cn",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"中国","RECRUITING","Suzhou","Jiangsu","215006","China","CN",{"type":34,"coordinates":35},"Point",[36,37],120.59538,31.30408,{"lat":37,"lon":36},[40],{"name":20,"role":21,"phone":41,"phoneExt":7,"email":23},"051265223637",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Qi Xiao-Fei","Principal Investigator","100297187","fmt-in-gut-agvhd-treated-100297187",false,"NCT03148743","FMT in Gut aGVHD Treated","Department of Hematology of First Affiliated Hospital of Soochow University","Inclusion Criteria:\n\n* gut GVHD\n\nExclusion Criteria:\n\n* Age\\>60; or Age\\\u003C10",true,"ALL","10 Years","60 Years",{"count":58,"type":59},50,"ESTIMATED","OBSERVATIONAL","With the stem cell transplanting increasing, patients which effected with gut GVHD were also increased. To evaluation the safety and efficacy of FMT for gut GVHD,patients with gut GVHD were recruited.",[63],"Acute-graft-versus-host Disease","2026-05-28",{"date":66,"type":67},"2026-06-01","ACTUAL",{"date":69,"type":67},"2017-05-16",{"date":71,"type":59},"2029-12-01",{"name":5,"class":6},1]